Gastroesophageal reflux among different racial groups in the United States.

PubWeight™: 2.87‹?› | Rank: Top 1%

🔗 View Article (PMID 15188164)

Published in Gastroenterology on June 01, 2004

Authors

Hashem B El-Serag1, Nancy J Petersen, Junaia Carter, David Y Graham, Peter Richardson, Robert M Genta, Linda Rabeneck

Author Affiliations

1: Section of Gastroenterology, Houston Department of Veterans Affairs Medical Center (152), 2002 Holcombe Boulevard, Houston, TX 77030, USA. hasheme@bcm.tmc.edu

Associated clinical trials:

Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry | NCT00574327

Articles citing this

Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut (2005) 7.35

Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med (2006) 5.24

Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut (2013) 2.96

Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies. Am J Gastroenterol (2010) 2.37

Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005. Br J Cancer (2009) 2.33

Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms. Gut (2006) 2.28

Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006. Gut (2008) 2.08

Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev (2008) 1.89

Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial. Obesity (Silver Spring) (2013) 1.60

Impedance pH confirms the relationship between GERD and BMI. Dig Dis Sci (2012) 1.57

Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut (2007) 1.57

The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci (2008) 1.49

Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev (2005) 1.49

The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data. Dis Esophagus (2010) 1.42

Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men. Clin Gastroenterol Hepatol (2012) 1.41

Lifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twins. Gastroenterology (2006) 1.22

Clinical characteristics of asymptomatic esophagitis. J Gastroenterol (2008) 1.22

Racial and ethnic disparities in the prevalence of Barrett's esophagus among patients who undergo upper endoscopy. Clin Gastroenterol Hepatol (2007) 1.21

Trends in gastroesophageal reflux disease as measured by the National Ambulatory Medical Care Survey. Dig Dis Sci (2009) 1.21

Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma. Gastroenterology (2015) 1.21

Prevalence of gastroesophageal reflux disease symptoms and uninvestigated dyspepsia in Korea: a population-based study. Dig Dis Sci (2007) 1.20

Postmenopausal hormone use and symptoms of gastroesophageal reflux. Arch Intern Med (2008) 1.18

Prevalence of complicated gastroesophageal reflux disease and Barrett's esophagus among racial groups in a multi-center consortium. Dig Dis Sci (2009) 1.16

Meta-analyses of the effect of symptoms of gastroesophageal reflux on the risk of Barrett's esophagus. Am J Gastroenterol (2010) 1.10

The integrity of the esophageal mucosa. Balance between offensive and defensive mechanisms. Best Pract Res Clin Gastroenterol (2010) 1.08

Background factors of reflux esophagitis and non-erosive reflux disease: a cross-sectional study of 10,837 subjects in Japan. PLoS One (2013) 1.05

Dietary patterns and the risk of Barrett's esophagus. Am J Epidemiol (2008) 1.03

GERD symptoms in the general population: prevalence and severity versus care-seeking patients. Dig Dis Sci (2014) 0.96

Erosive esophagitis in asymptomatic subjects: risk factors. Dig Dis Sci (2009) 0.95

Cholangiocarcinoma: new insights into disease pathogenesis and biology. Infect Dis Clin North Am (2010) 0.94

The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model. Cancer Epidemiol Biomarkers Prev (2011) 0.91

Association of low serum adiponectin levels with erosive esophagitis in men: an analysis of 2405 subjects undergoing physical check-ups. J Gastroenterol (2011) 0.91

Laparoscopic Nissen fundoplication in Korean patients with gastroesophageal reflux disease. Yonsei Med J (2009) 0.89

African Americans with Barrett's esophagus are less likely to have dysplasia at biopsy. Dig Dis Sci (2011) 0.89

Risk factors for gastroesophageal reflux disease: the role of diet. Prz Gastroenterol (2014) 0.88

Epidemiological features of gastro-esophageal reflux disease in Iran based on general population. Gastroenterol Hepatol Bed Bench (2012) 0.87

Impact of gender and age on the long-term outcome of laparoscopic fundoplication. World J Surg (2009) 0.87

Contemplating the future without Helicobacter pylori and the dire consequences hypothesis. Helicobacter (2007) 0.87

Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma. PLoS One (2010) 0.87

Comparison of reflux esophagitis and its complications between African Americans and non-Hispanic whites. World J Gastroenterol (2009) 0.87

Effects of estrogen with and without progestin and obesity on symptomatic gastroesophageal reflux. Gastroenterology (2008) 0.86

The effect of abdominal visceral fat, circulating inflammatory cytokines, and leptin levels on reflux esophagitis. J Neurogastroenterol Motil (2015) 0.84

Relationship between gastroesophageal reflux symptoms and dietary factors in Korea. J Neurogastroenterol Motil (2011) 0.83

Prevalence and associated features of gastroesophageal reflux symptoms in a Caucasian-predominant adolescent school population. Dig Dis Sci (2008) 0.83

Evidence of a broad histamine footprint on the human exercise transcriptome. J Physiol (2016) 0.83

Prevalence of gastroesophageal reflux symptoms in a large unselected general population in Japan. World J Gastroenterol (2008) 0.83

Gastroesophageal reflux disease symptoms: prevalence, sociodemographics and treatment patterns in the adult Israeli population. World J Gastroenterol (2011) 0.83

Binge eating, body mass index, and gastrointestinal symptoms. J Psychosom Res (2013) 0.80

Prevalence of dysphagia in patients with gastroesophageal reflux in Germany. Dysphagia (2008) 0.80

Prospective randomized controlled trial of an injectable esophageal prosthesis versus a sham procedure for endoscopic treatment of gastroesophageal reflux disease. Surg Endosc (2010) 0.80

Population-based assessment of heartburn in urban Black Americans. Dis Esophagus (2012) 0.79

Chemoprevention of esophageal adenocarcinoma. Therap Adv Gastroenterol (2008) 0.79

Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterol Clin North Am (2015) 0.79

Obesity and the rising incidence of oesophageal and gastric adenocarcinoma: what is the link? Gut (2007) 0.79

Acid-related upper endoscopy findings in patients with diabetes versus non-diabetic patients. Dig Dis Sci (2010) 0.79

Tongue-like Barrett's esophagus is associated with gastroesophageal reflux disease. World J Gastroenterol (2008) 0.78

Gastroesophageal reflux disease and non-esophageal cancer. World J Gastroenterol (2015) 0.78

Risk factors for neoplastic progression in Barrett's esophagus. World J Gastroenterol (2011) 0.77

Lifestyle characteristics and gastroesophageal reflux disease: a population-based study in Albania. Gastroenterol Res Pract (2013) 0.77

Temporal trends of esophageal disorders by age in the Cerner Health Facts database. Ann Epidemiol (2015) 0.76

Gastroesophageal reflux disease. Recent findings in GERD research. Rev Gastroenterol Disord (2005) 0.75

Erosive Esophagitis in the Obese: The Effect of Ethnicity and Gender on Its Association. Gastroenterol Res Pract (2016) 0.75

Central Obesity as a Risk Factor for Non-Erosive Reflux Disease. Yonsei Med J (2017) 0.75

Are We Making Progress in Preventing Barrett's-Related Esophageal Cancer? Therap Adv Gastroenterol (2009) 0.75

Early referral for 24-h esophageal pH monitoring may prevent unnecessary treatment with acid-reducing medications. Surg Endosc (2012) 0.75

Upper gastrointestinal hemorrhage: have new therapeutics made a difference? J Hosp Med (2009) 0.75

GERD in Minority Populations. Gastroenterol Hepatol (N Y) (2011) 0.75

Racial Disparity in the Sex Distribution, the Prevalence, and the Incidence of Dysplasia in Barrett's Esophagus. J Clin Gastroenterol (2016) 0.75

Dietary carbohydrate intake, insulin resistance and gastro-oesophageal reflux disease: a pilot study in European- and African-American obese women. Aliment Pharmacol Ther (2016) 0.75

Epidemiology of upper gastrointestinal symptoms in Brazil (EpiGastro): a population-based study according to sex and age group. World J Gastroenterol (2014) 0.75

Does Nissen Fundoplication Provide Lifelong Reflux Control? Symptomatic Outcome After 31-33 Years. World J Surg (2017) 0.75

Racial Disparity in Gastrointestinal Cancer Risk. Gastroenterology (2017) 0.75

Hiatal hernia and gastroesophageal reflux: Study of collagen in the phrenoesophageal ligament. Surg Endosc (2016) 0.75

Association between coffee or tea drinking and Barrett's esophagus or esophagitis: an Italian study. Eur J Clin Nutr (2017) 0.75

Gastroesophageal reflux disease prevalence among school teachers of Saudi Arabia and its impact on their daily life activities. Int J Health Sci (Qassim) (2017) 0.75

Articles by these authors

A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med (2002) 16.75

Association of colonoscopy and death from colorectal cancer. Ann Intern Med (2008) 15.51

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut (2012) 12.62

Traces of human migrations in Helicobacter pylori populations. Science (2003) 11.92

Retention in care: a challenge to survival with HIV infection. Clin Infect Dis (2007) 10.66

The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med (2003) 6.06

Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med (2002) 5.83

Factors associated with incomplete colonoscopy: a population-based study. Gastroenterology (2007) 5.30

Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis (2002) 5.09

Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology (2007) 4.37

A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc (2010) 4.26

Hospital use and survival among Veterans Affairs beneficiaries. N Engl J Med (2003) 4.13

Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology (2010) 3.91

Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med (2011) 3.78

Norwalk virus shedding after experimental human infection. Emerg Infect Dis (2008) 3.70

Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. N Engl J Med (2005) 3.57

The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs. Arch Intern Med (2006) 3.44

Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol (2005) 3.34

Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology (2002) 3.27

Canadian Association of Gastroenterology position statement on screening individuals at average risk for developing colorectal cancer: 2010. Can J Gastroenterol (2010) 3.20

The peopling of the Pacific from a bacterial perspective. Science (2009) 3.14

Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score. J Clin Gastroenterol (2012) 2.99

Gaps in the achievement of effectiveness of HCV treatment in national VA practice. J Hepatol (2011) 2.96

International comparisons of manpower in gastroenterology. Am J Gastroenterol (2007) 2.95

Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study. Clin Gastroenterol Hepatol (2008) 2.91

Medical disease and alcohol use among veterans with human immunodeficiency infection: A comparison of disease measurement strategies. Med Care (2006) 2.82

Death of an Arabian Jew. Arch Intern Med (2004) 2.73

Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet (2002) 2.71

Identification of rheumatoid arthritis patients using an administrative database: a Veterans Affairs study. Arthritis Care Res (Hoboken) (2012) 2.67

Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology (2010) 2.64

Information overload and missed test results in electronic health record-based settings. JAMA Intern Med (2013) 2.60

Missed opportunities to initiate endoscopic evaluation for colorectal cancer diagnosis. Am J Gastroenterol (2009) 2.60

Lymphocytic oesophagitis: clinicopathological aspects of an emerging condition. Gut (2011) 2.59

Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest (2005) 2.59

Decreased risk of celiac disease in patients with Helicobacter pylori colonization. Am J Epidemiol (2013) 2.58

Helicobacter pylori in North and South America before Columbus. FEBS Lett (2002) 2.57

Development and use of reporting guidelines for assessing the quality of validation studies of health administrative data. J Clin Epidemiol (2010) 2.54

A national study of Helicobactor pylori infection in gastric biopsy specimens. Gastroenterology (2010) 2.53

Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis (2013) 2.50

A population-based analysis of outpatient colonoscopy in adults assisted by an anesthesiologist. Anesthesiology (2009) 2.41

A report card to grade Helicobacter pylori therapy. Helicobacter (2007) 2.41

Greater prevalence and incidence of dementia in older veterans with posttraumatic stress disorder. J Am Geriatr Soc (2010) 2.38

Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol (2007) 2.36

Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology (2002) 2.32

The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol (2009) 2.31

Screening colonoscopy in very elderly patients: prevalence of neoplasia and estimated impact on life expectancy. JAMA (2006) 2.27

Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol (2010) 2.26

Impact of race on health care utilization and outcomes in veterans with congestive heart failure. J Am Coll Cardiol (2004) 2.21

Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis (2010) 2.21

National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002. Gastrointest Endosc (2002) 2.20

Colonoscopic miss rates for right-sided colon cancer: a population-based analysis. Gastroenterology (2004) 2.17

Understanding racial disparities in HIV using data from the veterans aging cohort 3-site study and VA administrative data. Am J Public Health (2003) 2.16

Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection. Clin Gastroenterol Hepatol (2009) 2.15

Rates of new or missed colorectal cancer after barium enema and their risk factors: a population-based study. Am J Gastroenterol (2008) 2.14

How harmful is hazardous alcohol use and abuse in HIV infection: do health care providers know who is at risk? J Acquir Immune Defic Syndr (2003) 2.14

Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology (2009) 2.05

Efficiency of an endoscopy suite in a teaching hospital: delays, prolonged procedures, and hospital waiting times. Gastrointest Endosc (2006) 2.04

Comparing the Blatchford and pre-endoscopic Rockall score in predicting the need for endoscopic therapy in patients with upper GI hemorrhage. Gastrointest Endosc (2010) 2.04

Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology (2005) 2.03

Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication. Helicobacter (2009) 2.02

Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol (2006) 1.99

Optimal therapy for Helicobacter pylori infections. Nat Rev Gastroenterol Hepatol (2011) 1.98

Gastritis staging in clinical practice: the OLGA staging system. Gut (2006) 1.90

Helicobacter pylori is a risk factor for colonic neoplasms. Am J Gastroenterol (2012) 1.89

Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology (2011) 1.86

Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology (2002) 1.79

Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States. Clin Gastroenterol Hepatol (2009) 1.76

Risk factors for immediate and delayed bleeding associated with endoscopic submucosal dissection of gastric neoplastic lesions. Scand J Gastroenterol (2009) 1.75

NSAIDs, Helicobacter pylori, and Pandora's Box. N Engl J Med (2002) 1.75

Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days. Helicobacter (2011) 1.73

Colorectal cancer screening with nurse-performed flexible sigmoidoscopy: results from a Canadian community-based program. Gastrointest Endosc (2006) 1.72

Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: a Veterans Affairs cohort study. Am J Gastroenterol (2005) 1.72

Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori. J Clin Microbiol (2002) 1.72

Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. Arch Intern Med (2004) 1.70

Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011. Cancer Epidemiol (2013) 1.69

Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer (2002) 1.69

Biliary stenting in the management of large or multiple common bile duct stones. Gastrointest Endosc (2010) 1.68

Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch Intern Med (2006) 1.68

Population-based assessment of the surgical management of locally advanced colorectal cancer. J Natl Cancer Inst (2006) 1.66

Helicobacter pylori and idiopathic thrombocytopenic purpura. Ann Intern Med (2004) 1.65

Diffusion tensor imaging of mild to moderate blast-related traumatic brain injury and its sequelae. J Neurotrauma (2010) 1.65

Effectiveness of national provider prescription of PPI gastroprotection among elderly NSAID users. Am J Gastroenterol (2008) 1.64

Management of gastric polyps: a pathology-based guide for gastroenterologists. Nat Rev Gastroenterol Hepatol (2009) 1.62

Association of psychiatric disorders and sleep apnea in a large cohort. Sleep (2005) 1.62

Comparative effectiveness of goal setting in diabetes mellitus group clinics: randomized clinical trial. Arch Intern Med (2011) 1.61

The prevalence of suspected Barrett's esophagus in children and adolescents: a multicenter endoscopic study. Gastrointest Endosc (2006) 1.60

Role of interferon-stimulated responsive element-like element in interleukin-8 promoter in Helicobacter pylori infection. Gastroenterology (2004) 1.59

Endoscopic manifestations of gastroesophageal reflux disease in patients between 18 months and 25 years without neurological deficits. Am J Gastroenterol (2002) 1.58

Helicobacter pylori infection in mice: Role of outer membrane proteins in colonization and inflammation. Gastroenterology (2002) 1.58

The diagnostic value of the duodenal biopsy: a clinico-pathologic analysis of 28,000 patients. Dig Liver Dis (2009) 1.58

Iron deficiency and Helicobacter pylori infection in the United States. Am J Epidemiol (2005) 1.57

Clinical importance of HIV and depressive symptoms among veterans with HIV infection. J Gen Intern Med (2002) 1.57

Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors. Arch Intern Med (2005) 1.56

Endoscopic demonstration of transient small bowel intussusception in a patient with adult celiac disease. Gastrointest Endosc (2003) 1.55

Risk of colorectal cancer among Caucasian and African American veterans with ulcerative colitis. Inflamm Bowel Dis (2011) 1.53

Adherence to biopsy guidelines increases celiac disease diagnosis. Gastrointest Endosc (2011) 1.52

Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Gastroenterology (2010) 1.51

Helicobacter pylori-negative gastritis: prevalence and risk factors. Am J Gastroenterol (2012) 1.51